======= TET3 ======= == Gene Information == * **Official Symbol**: TET3 * **Official Name**: tet methylcytosine dioxygenase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=200424|200424]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43151|O43151]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TET3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TET3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613555|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5- hydroxymethylcytosine (5hmC) and plays a key role in epigenetic chromatin reprogramming in the zygote following fertilization. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation (By similarity). Selectively binds to the promoter region of target genes and contributes to regulate the expression of numerous developmental genes (PubMed:23217707). In zygotes, DNA demethylation occurs selectively in the paternal pronucleus before the first cell division, while the adjacent maternal pronucleus and certain paternally-imprinted loci are protected from this process. Participates in DNA demethylation in the paternal pronucleus by mediating conversion of 5mC into 5hmC, 5fC and 5caC. Does not mediate DNA demethylation of maternal pronucleus because of the presence of DPPA3/PGC7 on maternal chromatin that prevents TET3- binding to chromatin (By similarity). In addition to its role in DNA demethylation, also involved in the recruitment of the O- GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT (PubMed:23353889). {ECO:0000250|UniProtKB:Q8BG87, ECO:0000269|PubMed:23217707, ECO:0000269|PubMed:23353889}. |zf-CXXC| |TET DSBH| |TET Cys rich| |DNA demethylation of male pronucleus| |5-methylcytosine catabolic process| |5-methylcytosine metabolic process| |chromatin reprogramming in the zygote| |methylcytosine dioxygenase activity| |male pronucleus| |DNA methylation involved in embryo development| |changes to DNA methylation involved in embryo development| |female pronucleus| |histone H3-K4 trimethylation| |DNA demethylation| |oxidative demethylation| |DNA dealkylation| |peptidyl-lysine trimethylation| |histone H3-K4 methylation| |pyrimidine-containing compound catabolic process| |DNA methylation| |DNA alkylation| |demethylation| |DNA methylation or demethylation| |histone lysine methylation| |DNA modification| |peptidyl-lysine methylation| |histone methylation| |pyrimidine-containing compound metabolic process| |protein O-linked glycosylation| |chromosome| |iron ion binding| |protein alkylation| |protein methylation| |macromolecule methylation| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |methylation| |peptidyl-lysine modification| |glycoprotein biosynthetic process| |histone modification| |covalent chromatin modification| |glycoprotein metabolic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |organic cyclic compound catabolic process| |carbohydrate derivative biosynthetic process| |chromatin organization| |DNA metabolic process| |peptidyl-amino acid modification| |oxidation-reduction process| |embryo development| |carbohydrate derivative metabolic process| |organonitrogen compound catabolic process| |chromosome organization| |positive regulation of transcription by RNA polymerase II| |organonitrogen compound biosynthetic process| |DNA binding| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |organic substance catabolic process| |cellular catabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3234 * **Expression level (log2 read counts)**: 6.89 {{:chemogenomics:nalm6 dist.png?nolink |}}